CPT® 0569U, Under Proprietary Laboratory Analyses
The Current Procedural Terminology (CPT®) code 0569U as maintained by American Medical Association, is a medical procedural code under the range - Proprietary Laboratory Analyses.
Subscribe to Codify by AAPC and get the code details in a flash.
Tabs
Summary
This is a Proprietary Laboratory Analyses (PLA) code, meaning that the code applies to only one unique lab test made by a specific manufacturer or performed by a specific lab. Report 0569U only for Guardant Reveal™ from Guardant Health Inc. This test uses next–generation sequencing (NGS) to examine more than 20,000 regions of DNA for abnormal methylation patterns associated with solid tumors. It analyzes circulating tumor DNA (ctDNA) in a blood sample to detect the presence or absence of tumor–derived genetic material. When appropriate, the result includes a tumor fraction value.
For clinical responsibility, terminology, tips and additional info
start codify free trial.
View any code changes for 2025 as well as historical information on code creation and revision.
Tabs
Combat the #1 denial reason - mismatched CPT-ICD-9 codes - with top Medicare carrier and private payer accepted diagnoses for the chosen CPT® code.
View the CPT® code's corresponding procedural code and DRG. In a click, check the DRG's IPPS allowable, length of stay, and more. To plug inpatient facility revenue drains, subscribe to DRG Coder today.
Crosswalk to an anesthesia code and its base units, and calculate payments in a snap! Subscribe to Anesthesia Coder today.
View matching HCPCS Level II codes and their definitions.
Read a CPT® Assistant article by subscribing to Code Connect Today!
Search across Medicare Manuals, Transmittals, and more. For FREE Trial, register now!